Research at DDB extends findings from structural biology and cell-based systems to studies on the functions of receptors, ion channels and cytokines in physiological processes and mechanisms of disease. This includes investigating their regulation by endogenous and exogenous substances.
Our projects encompass studies of behaviour, cardiovascular function, metabolic homeostasis, inflammation, pain, tumour growth and metastasis. This work utilises state-of-the art approaches, including CRISPR-generated mutant mice, metabolic profiling, behavioural analyses and whole-animal imaging.
|Analytical & Structural Neuropharmacology||Cancer & Neural-Immune Regulation|
|Dr Celine Valant||Dr David Thal||Prof Arthur Christopoulos||A/Prof Erica Sloan|
|Cardiac GPCR Pharmacology||Cellular & Molecular Metabolism|
|Dr Lauren May||A/Prof Paul White||Prof Mark Febbraio|
|Heart Failure Pharmacology||Integrated Neurogenic Mechanisms|
|Prof Rebecca Ritchie||Dr Simona Carbone||Dr Daniel Poole||Dr Nicholas Veldhuis|
|Male Reproductive Pharmacology||Metabolic GPCR Biology|
|Dr Sab Ventura||Dr Betty Exintaris||Prof Patrick Sexton||A/Prof Denise Wootten|
|Molecular & Translational Drug Discovery|
|Dr Chris Langmead|